The invention relates to carboxamide derivatives as defined in the specification and claims, to a process for their preparation, to pharmaceutical compositions comprising them and to their use as mGluR1 enhancers in the treatment and prevention of neurological disorders and diseases, such as Alzheimer's disease and dementia.
本发明涉及如规范和权利要求中所定义的羧酰胺衍
生物,涉及它们的制备方法,包括它们的制药组合物以及它们作为mGluR1增强剂在治疗和预防神经系统疾病和疾病,如阿尔茨海默病和痴呆症中的用途。